TY - JOUR AU - Nerkar, Damini AU - Mukherjee, Aniruddha AU - Mehta, Bina Kumari AU - Banerjee, Sugato PY - 2015/07/01 Y2 - 2024/03/28 TI - METABOLIC SYNDROME ASSOCIATED COMPLICATIONS JF - International Journal of Pharmacy and Pharmaceutical Sciences JA - Int J Pharm Pharm Sci VL - 7 IS - 7 SE - Review Article(s) DO - UR - https://journals.innovareacademics.in/index.php/ijpps/article/view/6169 SP - 22-25 AB - <p>Metabolic syndrome (MetS) is characterized by a cluster of disorders like obesity, insulin resistance, glucose intolerance, hypertension and dyslipidemia. All these disorders are responsible for the development of secondary morbid and co-morbid conditions. The current review focuses on the molecular pathogenesis of secondary late complications associated with metabolic syndrome including cognitive impairment, depressive disorder, neuropathy, arthritis and colorectal cancer.</p><p> </p> ER -